Annual Meeting News

NEW YORK & TOKYO--(BUSINESS WIRE)--Today, Nihon Global Growth Partners Management Inc. (“NHGGP”) announced that it has nominated, via an affiliated fund, two qualified outside directors for election to the Board of Toyo Suisan Kaisha Ltd. (2875.T) (“Toyo Suisan” or the “Company”) at the upcoming Annual General Meeting. The investor group led by NHGGP collectively owns approximately 4% of Toyo Suisan’s common shares. NHGGP also issued a presentation detailing the case for change at the Board lev...

TORONTO--(BUSINESS WIRE)--Choice Properties Real Estate Investment Trust (“Choice Properties”) (TSX: CHP.UN) announced today that all of the trustee nominees listed in the management proxy circular dated March 14, 2025, were elected as trustees of Choice Properties. The vote was conducted at Choice Properties' Annual Meeting of Unitholders, held virtually, on April 24, 2025. The results of the vote are set out below: Trust Units Name of Nominee Votes For Votes Against L. Jay Cross 222,870,232 9...

BENTONVILLE, Ark.--(BUSINESS WIRE)--Walmart Inc. (NYSE: WMT) issued its 2025 Annual Report and filed its Proxy Statement today in preparation for the company’s Annual Shareholders’ Meeting on Thursday, June 5, 2025. 2025 Annual Report Highlights In his annual letter to shareholders and associates, Walmart President and Chief Executive Officer, Doug McMillon, expressed his appreciation for Walmart associates who drove the year’s strong performance, and highlighted the company’s impressive growth...

SAN FRANCISCO--(BUSINESS WIRE)--Eventbrite (NYSE: EB), a global marketplace for shared experiences, announced that it will release its financial results for the first quarter ended March 31, 2025, after the market closes on Thursday, May 8, 2025. Starting with the release of its first quarter 2025 results, Eventbrite will no longer publish a quarterly letter to shareholders. The company’s earnings press release, presentation and webcast will be available via Eventbrite’s investor relations webs...

PARIS--(BUSINESS WIRE)--Combined Shareholders’ General Meeting, April 24, 2025...

PARIS--(BUSINESS WIRE)--Regulatory News: Getlink SE (Paris:GET): The combined general meeting (ordinary and extraordinary) is convened on 14 May 2025 at 10:00 a.m (CET) at “Chateauform’ Le 28 George V”, 28, avenue George-V, 75008 Paris, France. The notice of meeting and the convening notice (which include the agenda of the meeting and the draft resolutions) were published in the French BALO (Bulletin des Annonces Légales Obligatoires) dated respectively April 23, 2025 and March 14, 2025. In acc...

ST. LOUIS--(BUSINESS WIRE)--As publicly announced, the annual meeting will be held on Friday, April 25, 2025 at 9:30 a.m. Central Time. Shareholders as of the close of business on the record date of February 26, 2025, and their legal proxies and other interested parties may attend the virtual annual meeting at https://meetnow.global/MDFX7M2. Shareholders as of the close of business on the record date, who have a control number may attend the annual meeting virtually as a “Shareholder” and may v...

BEVERLY, Mass.--(BUSINESS WIRE)--Glycologix, Inc. (“Glycologix”), a clinical-stage company developing biopolymers for the protection and repair of soft tissues, announced that clinical results from its multi-center, Phase 1b study of GLX-100 in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) will be presented at the American Urological Association (AUA) 2025 Annual Meeting in Las Vegas, Nevada. Podium presentation details: Title: A Phase 1b, First-in-Human, Open-label, Single-Arm Study Eva...

TORONTO--(BUSINESS WIRE)--Trigon Metals Inc. (TSX-V: TM, OTCQB: PNTZF) (“Trigon” or the “Company”) announces that it will be holding its annual and special meeting of common shareholders on Wednesday, June 11, 2025, at 10:00 a.m. ET (the “Meeting”) to, among other matters, vote on the proposed sale of the Company’s ownership interest in the Kombat Mine to Horizon Corporation Limited (the “Proposed Transaction”). Trigon and Horizon are in the final stages of negotiation the definitive share purc...

OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “ONO”) announced that it will present positive results from the Phase 2 PROSPECT study of tirabrutinib (ONO-4059) for the treatment of relapsed or refractory primary central nervous system lymphoma during an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) being held May 30 to June 3, 2025, in Chicago, Illinois. The company will al...